Effect of glutamine on methotrexate efficacy and toxicity

Annals of Surgery

Volumn 227, Issue 5, 1998, Pages 772-780

  Rubio, Isabel T ^a   Cao, Yihong ^a   Hutchins, Laura F ^b   Westbrook, Kent C ^a   Klimberg, V Suzanne ^a,c  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; GLUTAMINE; GLYCINE; METHOTREXATE;

ADULT; ANIMAL EXPERIMENT; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG MIXTURE; ENTEROCOLITIS; ENZYME ACTIVITY; FIBROSARCOMA; FOLLOW UP; FOOD INTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MALE; MORPHOMETRICS; MUCOSA INFLAMMATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEIN ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RAT; STATISTICAL ANALYSIS; TUMOR CELL CULTURE;

ADULT; AGED; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BREAST NEOPLASMS; EVALUATION STUDIES; FEMALE; GLUTAMINE; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; METHOTREXATE; MIDDLE AGED; RANDOM ALLOCATION; RATS; RATS, INBRED F344; SURVIVAL ANALYSIS;

EID: 0345404243     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199805000-00018     Document Type: Conference Paper

References (37)

1. Souba WW, Wilmore DW. Diet and nutrition in the care of the patient with surgery, trauma, and sepsis. In: Shells ME, Young VR, eds. Modern Nutrition in Health and Disease. Philadelphia: Lea & Febiger; 1988:1306-1336.
2. Hryniuk WM. Average relative dose intensity and the impact on design of clinical trials. Semin Oncol 1987; 14:65-74.
3. Yap HY, Blumenschein GR, Yap BS, et al. High-dose methotrexate for advanced breast cancer. Cancer Treat Rep 1979; 63:757-761.
4. Nirenberg A, Mosende C, Mehta BM, et al. High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicity. Cancer Treat Rep 1977; 61:779-783.
5. Frisell WR. Synthesis and catabolism of nucleotides. In: Frisell WR, ed. Human Biochemistry. New York: MacMillan; 1982:292-304.
6. Newsholme EA, Crabtree B, Ardawi MSM. Glutamine metabolism in lymphocytes: its biochemical, physiological and clinical importance. Q J Exp Physiol 1985; 70:473-489.
7. Windmueller HG. Glutamine utilization by the small intestine. Adv Enzymol Relat Areas Mol Biol 1982; 53:202-231.
8. Zeilke RH, Ozand PT, Tildon JT, et al. Reciprocal regulation of glucose and glutamine utilization by cultured human diploid fibroblasts. J Cell Physiol 1985; 70:473-489.
9. Fox AD, Kripke SA, Berman JR, et al. Reduction of the severity of enterocolitis by glutamine-supplemented enteral diets. Surg Forum 1987; 38:43-45.
10. Fox AD, Kripke SA, DePaula J, et al. Effect on a glutamine-supplemented enteral diet on methotrexate-induced enterocolitis. JPEN 1988; 12(4):325.
11. Klimberg VS, Nwokedi E, Hutchins LF, et al. Does glutamine facilitate chemotherapy while reducing its toxicity? Surg Forum 1991; 42:16-18.
12. Klimberg VS, Nwokedi E, Hutchins LF, et al. Glutamine facilitates chemotherapy while reducing toxicity. JPEN 1992; 16(6):83S-87S.
13. Klimberg VS, Pappas AA, Nwokedi E, et al. Effect of supplemental dietary glutamine on methotrexate concentrations in tumors. Arch Surg 1992; 127:1317-1320.
14. Bergmeyer HU, ed. Methods of Enzymatic Analysis. New York: John Wiley & Sons; 1974:1704-1708.
15. Lowry OH, Rosenbrough WJ, Farr AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-275.
16. Windmueller HG. Phosphate-dependent glutaminase in the small intestine. Arch Biochem Biophys. 1977; 182:506-517.
17. Varela-Moreiras G, Seyoum E, Selhub J. Combined affinity and ion pair liquid chromatographies for the analysis of folate distribution in tissues. J Nutr Biochem 1991; 2:44-53.
18. Jolivet J, Schilsky RL. High-pressure liquid chromatography analysis of methotrexate polyglutamates in cultured human breast cancer cell. Biochem Pharm 1981; 30(11):1387-1390.
19. Klimberg VS, Souba WW, Salloum RM, et al. Glutamine-enriched diets support muscle glutamine metabolism without stimulating tumor growth. J Surg Res 1990; 48(4):319-323.
20. Fahr M, Kornbluth J, Blossom S, et al. Glutamine enhances immuno-regulation of tumor growth. JPEN 1994; 18(6):471.
21. Feng Z, Cao Y, Kornbluth J, et al. Glutamine prevents DMBA-induced breast cancer growth. Surg Forum 1996; 47:524-526.
22. Jolivet J, Schilsky RL, Bailey BD. The synthesis and retention of methotrexate polyglutamates in cultured human breast cancer cells. Ann NY Acad Sci 1982; 397:184-192.
23. Ackland SP, Schilsky RL. High-dose methotrexate: a critical reappraisal. J Clin Oncol 1987; 5(12):2017-2031.
24. Fry DW, Gewirtz DA, Yalowich JC, Goldman ID. Characteristics of the accumulation of methotrexate polyglutamate derivatives in Ehrlich ascites tumor cells and isolated rat hepatocytes. Adv Exp Med Biol 1983; 163:215-234.
25. Goldman ID. The membrane transport of methotrexate (NSC-740) and other folate compounds: relevance to rescue protocols. Cancer Chemother Rep (Part 3) 1975; 6(1):63-72.
26. Austgen TR, Dudrick PS, Sitren H, et al. The effects of glutamine-enriched total parenteral nutrition in tumor growth and host tissues. Ann Surg 1992; 215:107-113.
27. Rouse K, Nwokedi E, Woodliff J, et al. Glutamine enhances selectivity of chemotherapy through changes in glutathione metabolism. Ann Surg. 1995; 221(4):420-426.
28. Ziegler TR, Benfell K, Smith RJ, et al. Safety and metabolic effects of L-glutamine administration in humans. JPEN 1990; 14(suppl):137S-146S.
29. Schloerb PR, Amare M. Total parenteral nutrition with glutamine in bone marrow transplantation and other clinical applications (a randomized, double-blind study). JPEN 1993; 17(5):407-413.
30. Ziegler TR, Young LS, Benfell K, et al. Glutamine-supplemented parenteral nutrition improves nitrogen retention and reduces hospital mortality versus standard parenteral nutrition following bone marrow transplantation: a randomized, double-blind trial. Ann Intern Med 1992; 116:821-828.
31. Skubitz KM, Anderson PM. Oral glutamine to prevent chemotherapy-induced stomatitis: a pilot study. J Lab Clin Med 1996; 127(2):223-228.
32. Richards EW, Long CL, Pinkston JA, et al. The role of oral glutamine supplementation in the prevention of radiation-induced enterocolitis in prostate cancer patients. FASEB J 1992; 6(5):A1680.
33. Ihde DC, Johnston-Early A, Carney DN. Lack of efficacy of high-dose methotrexate by 30-hour infusion in patients with progressive small cell carcinoma of the lung. Cancer Treat Rep 1982; 66:1223-1225.
34. Doyle LA, Berg C, Bottino G, et al. Erythema and desquamation after high-dose chemotherapy. Ann Intern Med 1983; 98:611-613.
35. Lopez MJ, Porter KA. Inflammatory breast cancer. Surg Clin North Am 1996; 76(2):411-429.
36. Singletary SE, Ames FC, Buzdar AU. Management of inflammatory breast cancer. World J Surg 1994; 18:87-92.
37. Hande KR, Oldham RK, Fer MF, et al. Randomized study of high-dose chemotherapy in the treatment of extensive small cell lung cancer. Am J Med 1982; 73:413-419.